https://www.selleckchem.com/pr....oducts/penicillin-st
05). The addition of IC to CCRT was associated with survival improvement in OS, PFS, and DMFS in high-risk patients, while no survival difference was found between CCRT and IC+CCRT in low-risk patients. Our study can help clinicians select stage II-IVa NPC patients who benefit from IC, which is important in guiding individual treatment. Our study can help clinicians select stage II-IVa NPC patients who benefit from IC, which is important in guiding individual treatment. This study aimed to present a new approach of thoro
Like
Comment
Share
